investor
IP News
SCROLL DOWN
IP News.
’20 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES (KR, WO)
- Date
- 2021-06-10
- View
- 4157
’20 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES (KR, WO)
The present invention pertains to a pharmaceutical or food composition for preventing or treating proteopathies, the pharmaceutical or food composition containing a novel p62 ligand compound represented by chemical formula 1, or a stereoisomer, a solvate, a hydrate, or a prodrug thereof as an active ingredient. A p62 ligand compound according to the present invention activates selective autophagy in cells to selectively remove proteins, organelles, and coagulations in the body, and thus can be advantageously used as a pharmaceutical composition for preventing, ameliorating, or treating various proteinopathies.